![David Jin](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
David Jin
Vorstandsvorsitzender bei
GenExosome Technologies, Inc.
Vermögen: 36 771 $ am 31.05.2026
Profil
David K.
Jin is currently President, CEO, Director & Chief Medical Officer at GenExosome Technologies, Inc. since 2017.
Dr. Jin is also Chief Executive Officer & Director at Avalon Heathcare Systems, Inc. Formerly, Dr. Jin was President, Chief Executive Officer & Director at Avalon GloboCare Corp.
from 2016 to 2025.
Dr. Jin served as Chief Medical Officer at AdvisoryCloud, Inc. Dr. Jin was Chief Medical Officer at Lineage Cell Therapeutics, Inc. from 2009 to 2016.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 15.04.2026 | 103’000 ( 0.85% ) | 36 771 $ | 31.05.2026 |
Aktive Positionen von David Jin
| Unternehmen | Position | Beginn |
|---|---|---|
GenExosome Technologies, Inc.
 GenExosome Technologies, Inc. MiscellaneousMiscellaneous Operates as an investment holding company | Vorstandsvorsitzender | 27.09.2017 |
Avalon Heathcare Systems, Inc. | Vorstandsvorsitzender | - |
Ehemalige bekannte Positionen von David Jin
| Unternehmen | Position | Ende |
|---|---|---|
| AVALON GLOBOCARE CORP. | Vorstandsvorsitzender | 30.11.2025 |
| LINEAGE CELL THERAPEUTICS, INC. | Technik-/Wissenschafts-/F&E-Leiter | 01.01.2016 |
AdvisoryCloud, Inc.
 AdvisoryCloud, Inc. Miscellaneous Commercial ServicesCommercial Services Provides ranking services for leading executives | Technik-/Wissenschafts-/F&E-Leiter | - |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
30
Beziehungen ersten Grades
5
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 5 |
|---|---|
Lineage Cell Therapeutics, Inc.
 Lineage Cell Therapeutics, Inc. BiotechnologyHealth Technology Engages in research and development of therapeutic products for retinal & neurological diseases and disorders and oncology | Health Technology |
Avalon GloboCare Corp.
 Avalon GloboCare Corp. BiotechnologyHealth Technology Provides biotechnology and healthcare service | Health Technology |
AdvisoryCloud, Inc.
AdvisoryCloud, Inc. Miscellaneous Commercial ServicesCommercial Services Provides ranking services for leading executives | Commercial Services |
GenExosome Technologies, Inc.
GenExosome Technologies, Inc. MiscellaneousMiscellaneous Operates as an investment holding company | Miscellaneous |
Avalon Heathcare Systems, Inc. |
